Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Oral Topotecan Plus Temodar in the Treatment of Patients With Malignant Gliomas

NCT00610571 is registered in ClinicalTrials.gov with Katy Peters as lead sponsor.

NCT NCT00610571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00610571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Oral Topotecan Plus Temodar in the Treatment of Patients With Malignant Gliomas
Lead sponsor
Katy Peters
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2004
Completion date
April 30, 2012
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma, glioblastoma, gliosarcoma